Afstyla recombinant and Tafenoquine Succinate (Arakoda)
Determining the interaction of Afstyla recombinant and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Tafenoquine Succinate (Krintafel)
- Afstyla recombinant-Tafinlar
- Afstyla recombinant-Tafluprost
- Afstyla recombinant-Tafluprost ophthalmic
- Afstyla recombinant-Tagamet
- Afstyla recombinant-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Aftera
- Tafenoquine Succinate (Arakoda)-Aftertest Topical Pain Relief
- Tafenoquine Succinate (Arakoda)-Agalsidase beta
- Tafenoquine Succinate (Arakoda)-Agalsidase beta Intravenous
- Tafenoquine Succinate (Arakoda)-Agenerase
- Tafenoquine Succinate (Arakoda)-Aggrastat